These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32147765)

  • 1. Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors.
    Lyubimova NV; Timofeev YS; Mitrofanov AA; Bekyashev AK; Goncharova ZA; Kushlinskii NE
    Bull Exp Biol Med; 2020 Feb; 168(4):503-506. PubMed ID: 32147765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
    Vietheer JM; Rieger J; Wagner M; Senft C; Tichy J; Foerch C
    J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of brain tumours.
    Lyubimova NV; Toms MG; Fu RG; Bondarenko YV
    Klin Lab Diagn; 2013 Oct; (10):71-2, 40-2. PubMed ID: 24640102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.
    Tichy J; Spechtmeyer S; Mittelbronn M; Hattingen E; Rieger J; Senft C; Foerch C
    J Neurooncol; 2016 Jan; 126(2):361-9. PubMed ID: 26518540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
    Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
    Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The glio-fibrillar acid protein in blood serum of patients with brain tumors and neurological diseases of non-tumorous etiology].
    Lyubimova NV; Timofeiev YS; Sushlinskii NE
    Klin Lab Diagn; 2016 Aug; 61(8):466-9. PubMed ID: 30601636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.
    Leiss L; Mega A; Olsson Bontell T; Nistér M; Smits A; Corvigno S; Rahman MA; Enger PØ; Miletic H; Östman A
    Glia; 2020 May; 68(5):979-988. PubMed ID: 31769546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
    Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
    Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurospecific proteins in the serum of patients with brain tumors.
    Lyubimova NV; Toms MG; Popova EE; Bondarenko YV; Krat VB; Kushlinskii NE
    Bull Exp Biol Med; 2011 Apr; 150(6):732-4. PubMed ID: 22235430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
    Darlix A; Hirtz C; Mollevi C; Ginestet N; Tiers L; Jacot W; Lehmann S
    Int J Cancer; 2021 Oct; 149(8):1605-1618. PubMed ID: 34196964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers for glioblastoma multiforme.
    Quddusi A; Shamim MS
    J Pak Med Assoc; 2019 Jun; 69(6):913-914. PubMed ID: 31201406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochastic determination of the chromosomal region responsible for expression of human glial fibrillary acidic protein in astrocytic tumors.
    Yoshimine T; Maruno M; Kumura E; Ghulam Muhammad AK; Ninomiya H; Kato A; Hayakawa T
    Neurosci Lett; 1998 May; 247(1):29-32. PubMed ID: 9637402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the expression of glial fibrillary acid protein (GFAP) stain in glioblastoma tissue have a prognostic impact on survival?
    Ahmadipour Y; Gembruch O; Pierscianek D; Sure U; Jabbarli R
    Neurochirurgie; 2020 Jun; 66(3):150-154. PubMed ID: 32278699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-oncology: a step towards clinical blood biomarkers of glioblastoma.
    Preusser M
    Nat Rev Neurol; 2014 Dec; 10(12):681-2. PubMed ID: 25366110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of glial fibrillary acidic protein, vimentin, fibronectin, and N-myc oncoprotein in primary human brain tumor cell explants.
    Mapstone TB; Galloway PG
    Pediatr Neurosurg; 1991-1992; 17(4):169-74. PubMed ID: 1668298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of immunohistochemistry in neuro-oncology. I. Demonstration of glial fibrillary acid protein (GFAP) in extracranial metastases from primary brain tumors].
    Gottschalk J; Martin H; Kretschmer B; Barz H; Janda J; Szymas J
    Zentralbl Allg Pathol; 1985; 130(5):391-6. PubMed ID: 3913231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma-GFAP levels in metastatic myxopapillary ependymoma.
    Ilhan-Mutlu A; Berghoff AS; Furtner J; Dieckmann K; Slavc I; Czech T; Marosi C; Wagner L; Preusser M
    J Neurooncol; 2013 Jul; 113(3):359-63. PubMed ID: 23624779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.